Five Prime Therapeutics, Inc.
) was a big mover last session, as the company saw its shares
rise by roughly 23% on the day. The move came on solid volume too
with far more shares changing hands than in a normal
session. This continues the recent uptrend of the company
as the stock has now gained almost 67% since Mar 3.
This biotechnology company has seen no estimate revision over the
last 30 days while its Zacks Consensus Estimate moved higher over
the same time frame, suggesting that more solid trading could be
ahead for Five Prime Therapeutics. So make sure to keep an eye on
this stock going forward to see if this recent move higher can
turn into more strength down the road.
Five Prime Therapeutics has a Zacks Rank #3 (Hold) while its
Some better-ranked stocks in the industrial goods sector include
Alexion Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc.
). All these stocks hold a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research?
Today, you can download
7 Best Stocks for the Next 30 Days.
Click to get this free report >>
ALKERMES INC (ALKS): Free Stock Analysis
ALEXION PHARMA (ALXN): Free Stock Analysis
ANI PHARMACEUT (ANIP): Free Stock Analysis
FIVEPRIME THERA (FPRX): Free Stock Analysis
To read this article on Zacks.com click here.